NCT03417310 is a NA clinical trial of "H" joystick in Femur Shaft Fracture, sponsored by MGH Institute of Health Professions.

Who is sponsoring NCT03417310?

NCT03417310 is sponsored by MGH Institute of Health Professions.

What drugs are being tested in NCT03417310?

Interventions in NCT03417310: "H" joystick, Common reduction methods.

What condition does NCT03417310 study?

NCT03417310 studies Femur Shaft Fracture.

Is NCT03417310 still recruiting?

NCT03417310 is currently completed. Last updated 31 January 2018.

Last reviewed 2018-01-31 · How we verify

NCT03417310

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Applications of a Joystick in Femoral Shaft Fractures

Completed NA Last updated 31 January 2018

What this trial tests

NA trial testing "H" joystick in Femur Shaft Fracture in 80 participants. Completed in 31 March 2017.

Timeline

1 April 2015

Primary endpoint
31 March 2017

31 March 2017

Quick facts

Lead sponsor	MGH Institute of Health Professions
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	1 April 2015
Primary completion	31 March 2017
Estimated completion	31 March 2017
Sites	1 location across China

Drugs / interventions tested

"H" joystick
Common reduction methods

Conditions studied

Femur Shaft Fracture — all drugs for Femur Shaft Fracture →

Sponsor

MGH Institute of Health Professions

Who can join

Adults 18 to 80, any sex, with Femur Shaft Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will use a new "H" joystick for reduction on patients with femur fractures to investigate the reduction time, operating time and bone healing status for the evaluation of the clinical application benefits of this joystick.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other MGH Institute of Health Professions trials

Trials by the same sponsor.

NCT07489053 — Optimizing Functional Recovery After Breast Cancer Treatment · NA · not yet recruiting
NCT07349030 — Fall Risk Intervention for Stroke · NA · not yet recruiting
NCT06494423 — Employment Support After Hematopoietic Stem Cell Transplantation · NA · recruiting
NCT05066178 — Speech Treatment for Minimally Verbal Children With ASD and CAS · NA · recruiting
NCT06304207 — Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03417310 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by MGH Institute of Health Professions
Last refreshed: 31 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03417310.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing